Display options
Cite
Tembe DV, Dhavale A, Desai H, et al. Armodafinil versus Modafinil in Patients of Excessive Sleepiness Associated with Shift Work Sleep Disorder: A Randomized Double Blind Multicentric Clinical Trial. Neurol Res Int. 2011;2011:514351doi: 10.1155/2011/514351.
Tembe, D. V., Dhavale, A., Desai, H., Mane, D. N., Raut, S. K., Dhingra, G., Sardesai, U., Saoji, S., Rohra, M., Shinde, V. G., Padsalge, M., Paliwal, A., Abbasi, K., Devnani, P., Papinwar, S., Phadke, S., Mehta, H., & Bhailume, V. (2011). Armodafinil versus Modafinil in Patients of Excessive Sleepiness Associated with Shift Work Sleep Disorder: A Randomized Double Blind Multicentric Clinical Trial. Neurology research international, 2011514351. https://doi.org/10.1155/2011/514351
Tembe, D V, et al. "Armodafinil versus Modafinil in Patients of Excessive Sleepiness Associated with Shift Work Sleep Disorder: A Randomized Double Blind Multicentric Clinical Trial." Neurology research international vol. 2011 (2011): 514351. doi: https://doi.org/10.1155/2011/514351
Tembe DV, Dhavale A, Desai H, Mane DN, Raut SK, Dhingra G, Sardesai U, Saoji S, Rohra M, Shinde VG, Padsalge M, Paliwal A, Abbasi K, Devnani P, Papinwar S, Phadke S, Mehta H, Bhailume V. Armodafinil versus Modafinil in Patients of Excessive Sleepiness Associated with Shift Work Sleep Disorder: A Randomized Double Blind Multicentric Clinical Trial. Neurol Res Int. 2011;2011:514351. doi: 10.1155/2011/514351. Epub 2011 Jun 01. PMID: 21766023; PMCID: PMC3135062.
Copy Download .nbib Format: NLM
Share it on

Neurol Res Int. 2011;2011:514351. doi: 10.1155/2011/514351. Epub 2011 Jun 01.

Armodafinil versus Modafinil in Patients of Excessive Sleepiness Associated with Shift Work Sleep Disorder: A Randomized Double Blind Multicentric Clinical Trial.

Neurology research international

D V Tembe, A Dhavale, H Desai, D N Mane, S K Raut, G Dhingra, U Sardesai, S Saoji, M Rohra, V G Shinde, M Padsalge, A Paliwal, K Abbasi, P Devnani, S Papinwar, S Phadke, H Mehta, V Bhailume

Affiliations

  1. Manovedh Clinic, Karad 415110, India.

PMID: 21766023 PMCID: PMC3135062 DOI: 10.1155/2011/514351

Abstract

Aim. To compare the efficacy and safety of armodafinil, the R-enantiomer of modafinil, with modafinil in patients of shift work sleep disorder (SWSD). Material and Methods. This was a 12-week, randomized, comparative, double-blind, multicentric, parallel-group study in 211 patients of SWSD, receiving armodafinil (150 mg) or modafinil (200 mg) one hour prior to the night shift. Outcome Measures. Efficacy was assessed by change in stanford sleepiness score (SSS) by at least 2 grades (responder) and global assessment for efficacy. Safety was assessed by incidence of adverse events, change in laboratory parameters, ECG, and global assessment of tolerability. Results. Both modafinil and armodafinil significantly improved sleepiness mean grades as compared to baseline (P < .0001). Responder rates with armodafinil (72.12%) and modafinil (74.29%) were comparable (P = .76). Adverse event incidences were comparable. Conclusion. Armodafinil was found to be safe and effective in the treatment of SWSD in Indian patients. The study did not demonstrate any difference in efficacy and safety of armodafinil 150 mg and modafinil 200 mg.

References

  1. Psychophysiology. 1973 Jul;10(4):431-6 - PubMed
  2. CNS Drugs. 2001;15(4):311-28 - PubMed
  3. Clin Ther. 1996 Jul-Aug;18(4):562-76; discussion 561 - PubMed
  4. Clin Drug Investig. 2009;29(9):613-23 - PubMed
  5. Curr Med Res Opin. 2006 Jan;22(1):159-67 - PubMed
  6. Int J Biomed Sci. 2006 Jun;2(2):85-100 - PubMed
  7. Mayo Clin Proc. 2009 Nov;84(11):958-72 - PubMed
  8. J Clin Pharmacol. 1999 Jan;39(1):30-40 - PubMed
  9. N Engl J Med. 2005 Aug 4;353(5):476-86 - PubMed

Publication Types